1ALLISON R. Disseminated sclerosis in north Wales: an inquiry into its incidence, frequency, distribution and other aetiological factors[J]. Brain, 1931,53(2):391-430.
2ALLISON R, MILLAR J. Prevalence and familial incidence of disseminated sclerosis[J]. Ulster Med J, 1954,23(Suppl 2):1-92.
3POSER C. Clinical diagnostic criteria in epidemiological studies of multiple sclerosis[J]. Ann N Y Acad Sci, 1965,122(1):506-519.
4BROMAN T, BERGMANN L, FOG T, et al. Aspects on classification methods in multiple sclerosis[J]. Acta Neurol Scand, 1965,41(Suppl 13):543-548.
5SCHUMACHER G, BEEBE G, KIBLER R, et al. Problems of experimental trials of therapy in multiple sclerosis[J]. Ann N Y Acad Sci, 1965,122(2):552-568.
6McAlpine D, Lumsden C, Acheson E, editors. Multiple Sclerosis: a reappraisal. 2 nd ed.Baltimore: Williams and Wilkins, 1972.225-226.
7ROSE A, ELLISON G, MYERS L, et al. New diagnostic criteria for the clinical diagnosis of multiple sclerosis[J]. Neurology, 1976,26(Suppl):20-22.
8McDONALD W, HALLIDAY A. Diagnosis and classification of multiple sclerosis[J]. Br Med Bull, 1977,33(1):4-8.
9KUROIWA Y, ARAKI S, KATSUKI S. Clinical features of demyelinating diseases in Japan[J]. Proc Aust Assoc Neurol,1968,5(2):341-345.
10BAUER H. IMAB-enqu?ete concerning the diagnostic criteria for MS[A]. In: Bauer H, Poser S, Ritter G. Progress in Multiple Sclerosis Research[M]. Berlin: Springer Verlag, 1980. 555-563.
